Dishman Carbogen Amcis Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: DCAL BSE: 540701

₹157.47

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #73 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Dishman Carbogen Amcis Limited (this stock)	2,469	—	1.5%	-43.0%	—	35	100	11

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹3,084 Cr

EV / EBITDA

56.7x

EV / Sales

13.66x

Market cap / Sales

10.93x

Earnings yield

Data unavailable.

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 76 Cr, down 24.2% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	57	-32	-24	₹-1.5200
March 31, 2026	69	-7	-4	₹-0.2800
Dec. 31, 2025	40	-35	-23	₹-1.4700
Sept. 30, 2025	60	-21	-14	₹-0.8700
June 30, 2025	63	4	3	₹0.1700
March 31, 2025	106	-11	-7	₹-0.4700
Dec. 31, 2024	97	-19	-13	₹-0.8500
Sept. 30, 2024	93	5	14	₹0.9100
June 30, 2024	103	-6	-3	₹-0.2200
March 31, 2024	111	-34	-31	₹-1.9800
Dec. 31, 2023	87	-27	-18	₹-1.1600
Sept. 30, 2023	60	-9	-6	₹-0.3700
June 30, 2023	70	-33	-21	₹-1.3600

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	76	98	47	71	100	112	89	117	115	108	100	98	84
Operating revenue	57	69	40	60	63	106	97	93	103	111	87	60	70
Other income	19	29	7	11	37	5	-8	24	12	-3	13	39	14
Operating expenses	69	68	43	56	59	86	74	80	89	100	84	63	75
Operating profit	-12	1	-4	4	3	21	23	13	15	12	3	-3	-5
Operating profit margin	-20.7%	1.4%	-8.8%	7.3%	5.5%	19.3%	23.7%	14.4%	14.4%	10.4%	3.7%	-4.9%	-7.2%
Depreciation	15	15	15	16	16	16	16	16	16	26	26	25	25
Interest	22	22	24	21	20	21	18	16	16	16	17	17	18
Exceptional items, gain / (loss)	-2	—	—	—	—	—	—	—	—	—	—	-3	—
Profit before tax	-32	-7	-35	-21	4	-11	-19	5	-6	-34	-27	-9	-33
Tax	-8	-3	-12	-7	1	-4	-6	-9	-2	-3	-9	-3	-12
Net profit	—	—	—	—	3	—	-13	14	-3	-31	-18	-6	-21
EPS	-1.52	-0.28	-1.47	-0.87	0.17	-0.47	-0.85	0.91	-0.22	-1.98	-1.16	-0.37	-1.36
Net profit (TTM)	—	—	—	—	—	—	-34	-39	-59	-76	-56	-44	-55
EPS (TTM)	-4.14	-2.45	-2.64	-2.02	-0.24	-0.63	-2.14	-2.45	-3.73	-4.87	-3.54	-2.80	-3.53

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	232	-59	-38
March 31, 2025	400	-31	-10
March 31, 2024	327	-103	-76
March 31, 2023	403	-96	-59

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total income (before exceptional items)	-11.5%	2.9%	316^†	433^†	390^†	456^†	370^†	274^†	650^†	621^†
Operating revenue	-16.8%	2.1%	232	400	327	403	304^†	208^†	581^†	549^†
Other income	—	—	85^†	33^†	63^†	53^†	66^†	66^†	70^†	72^†
Operating expenses	—	—	226^†	328^†	321^†	395^†	270^†	265^†	407^†	356^†
Operating profit	-11.7%	—	5^†	72^†	7^†	8^†	34^†	-57^†	174^†	194^†
Operating profit margin	—	—	2.3%^†	18.0%^†	2.1%^†	1.9%^†	11.2%^†	-27.5%^†	29.9%^†	35.3%^†
Depreciation	—	—	63^†	65^†	102^†	96^†	141^†	143^†	141^†	136^†
Interest	—	—	87^†	70^†	68^†	58^†	37^†	34^†	47^†	47^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	-3^†	-2^†	-6^†	0^†	0^†	0^†
Profit before tax	—	—	-59	-31	-103	-96	-84^†	-168^†	55^†	82^†
Tax	—	—	-21^†	-21^†	-27^†	-37^†	-53^†	64^†	17^†	26^†
Net profit	—	—	-38	-10	-76	-59	-32^†	-233^†	39^†	56^†
EPS	—	—	-2.45^†	-0.63^†	-4.87^†	-3.75^†	-2.01^†	-14.84^†	2.39^†	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Operating margin	2.3%^†	18.0%^†	2.1%^†	1.9%^†	11.2%^†	-27.5%^†	29.9%^†	35.3%^†
EBIT margin	11.8%^†	9.9%^†	-10.6%^†	-9.5%^†	-15.5%^†	-64.5%^†	17.7%^†	23.5%^†
PBT margin	-25.6%	-7.7%	-31.5%	-23.9%	-27.7%^†	-80.9%^†	9.6%^†	14.9%^†
Net margin	-16.6%	-2.5%	-23.3%	-14.6%	-10.4%^†	-111.7%^†	6.6%^†	10.2%^†
Interest coverage	0.32x^†	0.56x^†	-0.51x^†	-0.66x^†	-1.27x^†	-3.93x^†	2.18x^†	2.72x^†
Dividend payout	—	—	—	—	—	—	8.4%^†	—
Earnings retention	—	—	—	—	—	—	91.6%^†	—
Current ratio	0.79x	1.04x	—	—	—	—	—	—
Quick ratio	0.62x	0.83x	—	—	—	—	—	—
Debt to equity	0.16x	0.17x	—	—	—	—	—	—
Return on equity	-1.0%	-0.2%	—	—	—	—	—	—
Return on assets	-0.7%	-0.2%	—	—	—	—	—	—
Return on capital employed	0.6%^†	0.9%^†	—	—	—	—	—	—
Asset turnover	0.05x	0.08x	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	46	22	-120	27	19
March 31, 2025	56	-80	88	55	1
March 31, 2024	24	97	-131	36	-12
March 31, 2023	-53	41	1	123	-176
March 31, 2022	227	-173	-46	39	188

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	5,126	3,882	3,851	507	124	690	869	16	782	155
March 31, 2025	5,122	4,030	3,999	431	248	675	652	68	798	134
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.